National Institute of Neurological Disorders and Stroke; Notice of Meeting, 14543 [2022-05465]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices
the meeting, depending on the volume
of comments received and the time
required to process them in accordance
with privacy regulations and other
applicable Federal policies. The
Committee is not able to individually
respond to comments. All public
comments become part of the public
record. Attachments of copyrighted
publications are not permitted, but web
links or citations for any copyrighted
works cited may be provided. For public
comment guidelines, see: https://
iacc.hhs.gov/meetings/publiccomments/guidelines/.
Technical Issues
If you experience any technical
problems with the webcast please email
IACCPublicInquiries@mail.nih.gov.
Meeting schedule subject to change.
Disability Accommodations
All IACC Full Committee Meetings
provide Closed Captioning through the
NIH videocast website. Individuals
whose full participation in the meeting
will require special accommodations
(e.g., sign language or interpreting
services, etc.) must submit a request to
the Contact Person listed on the notice
at least seven (7) business days prior to
the meeting. Such requests should
include a detailed description of the
accommodation needed and a way for
the IACC to contact the requester if
more information is needed to fill the
request. Special requests should be
made at least seven (7) business days
prior to the meeting; last-minute
requests may be made but may not be
possible to accommodate.
More Information
Information about the IACC is
available on the website: https://
www.iacc.hhs.gov.
Dated: March 10, 2022.
Melanie Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05468 Filed 3–14–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
VerDate Sep<11>2014
21:10 Mar 14, 2022
Jkt 256001
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below. Individuals
who plan to participate and need
special assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: May 18–19, 2022.
Open: May 18, 2022, 1:00 p.m. to 5:30 p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Activities; Administrative and
Program Developments; and Overview of the
NINDS Intramural Program.
Open session will be videocast from this
link: https://videocast.nih.gov/.
Closed: May 19, 2022, 1:00 p.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Closed: May 19, 2022, 5:00 p.m. to 5:30
p.m.
Agenda: To review and evaluate the
Division of Intramural Research Board of
Scientific Counselors’ Reports.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Rockville, MD 20852 (Virtual Meeting).
Contact Person: Robert Finkelstein, Ph.D.,
Director of Extramural Research, National
Institute of Neurological Disorders and
Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248, finkelsr@ninds.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice at
least 10 days in advance of the meeting.
The statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.ninds.nih.gov, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
14543
Neurosciences, National Institutes of Health,
HHS)
Dated: March 9, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05465 Filed 3–14–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; FEB2022
Cycle 40 NExT SEP Committee Meeting.
Date: April 18, 2022.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, Room 3A44,
Bethesda, Maryland 20892 (WebEx Meeting).
Contact Persons: Barbara Mroczkowski,
Ph.D., Executive Secretary, Discovery
Experimental Therapeutics Program,
National Cancer Institute, NIH, 31 Center
Drive, Room 3A44, Bethesda, MD 20817,
(301) 496–4291, mroczkoskib@mail.nih.gov.
Toby Hecht, Ph.D., Executive Secretary,
Development Experimental Therapeutics
Program, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 3W110,
Rockville, MD 20850, (240) 276–5683,
toby.hecht2@nih.gov.
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 87, Number 50 (Tuesday, March 15, 2022)]
[Notices]
[Page 14543]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05465]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Neurological Disorders and Stroke Council.
The meeting will be open to the public as indicated below.
Individuals who plan to participate and need special assistance, such
as sign language interpretation or other reasonable accommodations,
should notify the Contact Person listed below in advance of the
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Neurological Disorders and
Stroke Council.
Date: May 18-19, 2022.
Open: May 18, 2022, 1:00 p.m. to 5:30 p.m.
Agenda: Report by the Director, NINDS; Report by the Director,
Division of Extramural Activities; Administrative and Program
Developments; and Overview of the NINDS Intramural Program.
Open session will be videocast from this link: https://videocast.nih.gov/.
Closed: May 19, 2022, 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Closed: May 19, 2022, 5:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate the Division of Intramural
Research Board of Scientific Counselors' Reports.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Blvd., Rockville, MD 20852 (Virtual Meeting).
Contact Person: Robert Finkelstein, Ph.D., Director of
Extramural Research, National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531,
Bethesda, MD 20892, (301) 496-9248, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this notice
at least 10 days in advance of the meeting. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.ninds.nih.gov, where an agenda and any additional information
for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: March 9, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-05465 Filed 3-14-22; 8:45 am]
BILLING CODE 4140-01-P
